S144 CP101 Engraftment Drives Efficacy: Results from a Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for Prevention of Recurrent C. Difficile InfectionJessica R. Allegretti,Colleen R. Kelly,Thomas Louie,Monika Fisher,Susy Hota,Bharat Misra,Nicholas W. Van Hise,Eugene F. Yen,Jeff S. Bullock,John Pullman,Richard Nathan,Michael Silverman,Ian Davis,Sarah McGill,Ylaine Gerardin,Josh Silva,Sahil Khanna,Darrell Pardi,Robert Orenstein,Ari Grinspan,Najwa El-Nachef,Colleen S. Kraft,Shrish Budree,Thomas J. Borody,Zain KassamThe American Journal of Gastroenterology(2021)引用 1|浏览4AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要